Scandinavian Urethroplasty Study
SUPS
1 other identifier
interventional
151
3 countries
4
Brief Summary
A multicentre, prospective, randomized study comparing bulbar urethroplasty with excision and primary anastomosis or with an onlay grafting procedure using buccal mucosa.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2014
CompletedFirst Posted
Study publicly available on registry
December 22, 2014
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2021
CompletedNovember 3, 2021
October 1, 2021
5.4 years
December 17, 2014
October 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Degree of erectile dysfunction after surgery
Measured by changes in IIEF-5
up to one year
Penile complications
Measured by questionnaire made for this study
up to one year
Secondary Outcomes (2)
Occurrence of failure within the follow up period
One year
Occurrence of complications
From operation to one year
Study Arms (2)
End-to-end
ACTIVE COMPARATORExcision of the stricture and end-to-end anastomosis of the urethra.
Graft
ACTIVE COMPARATORIncision of the stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided.
Interventions
Incision of stricture and grafting procedure with buccal mucosa where the corpus spongiosum is not divided
Eligibility Criteria
You may qualify if:
- Patient with bulbar urethral stricture, length estimated by urethrography or endoscopy ≤ 2 cm
- Patient is able and willing to sign informed consent
- Patient is able and willing to complete all study requirements
You may not qualify if:
- Previous open urethroplasty
- Previous hypospadia surgery
- Previous surgery for congenital curvature or Mb Peyronie
- Previous pelvic irradiation therapy
- Known grave psychiatric disorder
- Haemophilia or other clotting disorders that cause bleeding diathesis
- Use of medication to increase erectile function, such as PDE5-inhibitors and intracavernous injections, during the study
- Any condition or situation, which, in the investigator's opinion, puts the patient at significant risk, could confound the study results, or may interfere significantly with the patient's participation in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- Sahlgrenska University Hospitalcollaborator
- Region Örebro Countycollaborator
- Helsinki University Central Hospitalcollaborator
Study Sites (4)
Helsinki University Hospital
Helsinki, 00029, Finland
Oslo University Hospital, Dept of Urology
Oslo, 0424, Norway
Sahlgrenska University Hospital, Dept of Urology
Gothenburg, 41345, Sweden
Örebro University Hospital, Dept of Urology
Örebro, 70185, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Schultz, MD
Consultant
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant, Head of section
Study Record Dates
First Submitted
December 17, 2014
First Posted
December 22, 2014
Study Start
September 1, 2015
Primary Completion
January 31, 2021
Study Completion
February 15, 2021
Last Updated
November 3, 2021
Record last verified: 2021-10